Cargando…
The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
BACKGROUND: It is presently unclear whether glycemic variability is associated with diabetic cardiovascular autonomic neuropathy (CAN). The aim of this study was to examine whether short- and/or long-term glycemic variability (GV) contribute to CAN. METHODS: A total of 110 patients with type 2 diabe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462181/ https://www.ncbi.nlm.nih.gov/pubmed/26041130 http://dx.doi.org/10.1186/s12933-015-0233-0 |
_version_ | 1782375627571068928 |
---|---|
author | Jun, Ji Eun Jin, Sang-Man Baek, Jongha Oh, Sewon Hur, Kyu Yeon Lee, Myung-Shik Lee, Moon-Kyu Kim, Jae Hyeon |
author_facet | Jun, Ji Eun Jin, Sang-Man Baek, Jongha Oh, Sewon Hur, Kyu Yeon Lee, Myung-Shik Lee, Moon-Kyu Kim, Jae Hyeon |
author_sort | Jun, Ji Eun |
collection | PubMed |
description | BACKGROUND: It is presently unclear whether glycemic variability is associated with diabetic cardiovascular autonomic neuropathy (CAN). The aim of this study was to examine whether short- and/or long-term glycemic variability (GV) contribute to CAN. METHODS: A total of 110 patients with type 2 diabetes who underwent three-day continuous glucose monitoring (CGM) completed five standardized autonomic neuropathy tests. Short-term GV was measured by the standard deviation (SD), coefficient of variation (CV) of glucose, and the mean amplitude of glycemic excursions (MAGE) in CGM. HbA1c variability was calculated from the intrapersonal SD, adjusted SD, and CV of serial HbA1c over 2-year period. CAN was defined as the presence of at least two abnormal parasympathetic function tests. The severity of CAN was evaluated by total scores of five autonomic function tests. RESULTS: In univariate analysis, not only SD and CV in CGM but also all parameters of HbA1c variability were significantly higher in the patients with CAN (n = 47, 42.7 %) than in those without CAN. In multivariate analysis, CV (Odds ratio [OR] 1.07, 95 % confidence interval [CI] 1.01–1.13; p = 0.033), but neither SD nor MAGE in CGM, independently correlated with the presence of CAN. All parameters of HbA1c variability, such as SD of HbA1c (OR 12.10 [95 % CI 2.29–63.94], p = 0.003), adjusted SD of HbA1c (OR 17.02 [95 % CI 2.66–108.86], p = 0.003), and log CV of HbA1c (OR 24.00 [95 % CI 3.09–186.48], p = 0.002), were significantly associated with the presence of CAN. The patients with higher HbA1c variability had an increased risk of advanced CAN. CONCLUSION: CV in CGM and all parameters of HbA1c variability were independently associated with the presence of CAN in patients with inadequately controlled type 2 diabetes requiring CGM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-015-0233-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4462181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44621812015-06-11 The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes Jun, Ji Eun Jin, Sang-Man Baek, Jongha Oh, Sewon Hur, Kyu Yeon Lee, Myung-Shik Lee, Moon-Kyu Kim, Jae Hyeon Cardiovasc Diabetol Original Investigation BACKGROUND: It is presently unclear whether glycemic variability is associated with diabetic cardiovascular autonomic neuropathy (CAN). The aim of this study was to examine whether short- and/or long-term glycemic variability (GV) contribute to CAN. METHODS: A total of 110 patients with type 2 diabetes who underwent three-day continuous glucose monitoring (CGM) completed five standardized autonomic neuropathy tests. Short-term GV was measured by the standard deviation (SD), coefficient of variation (CV) of glucose, and the mean amplitude of glycemic excursions (MAGE) in CGM. HbA1c variability was calculated from the intrapersonal SD, adjusted SD, and CV of serial HbA1c over 2-year period. CAN was defined as the presence of at least two abnormal parasympathetic function tests. The severity of CAN was evaluated by total scores of five autonomic function tests. RESULTS: In univariate analysis, not only SD and CV in CGM but also all parameters of HbA1c variability were significantly higher in the patients with CAN (n = 47, 42.7 %) than in those without CAN. In multivariate analysis, CV (Odds ratio [OR] 1.07, 95 % confidence interval [CI] 1.01–1.13; p = 0.033), but neither SD nor MAGE in CGM, independently correlated with the presence of CAN. All parameters of HbA1c variability, such as SD of HbA1c (OR 12.10 [95 % CI 2.29–63.94], p = 0.003), adjusted SD of HbA1c (OR 17.02 [95 % CI 2.66–108.86], p = 0.003), and log CV of HbA1c (OR 24.00 [95 % CI 3.09–186.48], p = 0.002), were significantly associated with the presence of CAN. The patients with higher HbA1c variability had an increased risk of advanced CAN. CONCLUSION: CV in CGM and all parameters of HbA1c variability were independently associated with the presence of CAN in patients with inadequately controlled type 2 diabetes requiring CGM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-015-0233-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-04 /pmc/articles/PMC4462181/ /pubmed/26041130 http://dx.doi.org/10.1186/s12933-015-0233-0 Text en © Jun et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Jun, Ji Eun Jin, Sang-Man Baek, Jongha Oh, Sewon Hur, Kyu Yeon Lee, Myung-Shik Lee, Moon-Kyu Kim, Jae Hyeon The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes |
title | The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes |
title_full | The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes |
title_fullStr | The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes |
title_full_unstemmed | The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes |
title_short | The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes |
title_sort | association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462181/ https://www.ncbi.nlm.nih.gov/pubmed/26041130 http://dx.doi.org/10.1186/s12933-015-0233-0 |
work_keys_str_mv | AT junjieun theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT jinsangman theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT baekjongha theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT ohsewon theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT hurkyuyeon theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT leemyungshik theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT leemoonkyu theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT kimjaehyeon theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT junjieun associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT jinsangman associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT baekjongha associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT ohsewon associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT hurkyuyeon associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT leemyungshik associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT leemoonkyu associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes AT kimjaehyeon associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes |